You've probably heard those advertisements for "the power of protein," referring to the addition of enzymes to detergent. Source: BioSpace

Stryker picked up controlling interest in Vexim, a French medical device company that specializes in the minimally invasive treatment of vertebral fractures. Source: BioSpace

Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace

TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace

ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace

Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze. Source: BioSpace

The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF). Source: BioSpace

Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace

The FDA based its decision on data from the COMBI-AD Phase III trial. Source: BioSpace

DBV's share price crumbled over the weekend after its Phase III peanut allergy trial failed to show a statistically significant response against placebo. Source: BioSpace